Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes-Reference-Cited by-同舟云学术

Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes

Published:2016-07 Issue:3 Volume:95 Page:960-964
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kotecha Rupesh,Djemil Toufik,Tendulkar Rahul D.,Reddy Chandana A.,Thousand Richard A.,Vassil Andrew,Stovsky Mark,Berglund Ryan K.,Klein Eric A.,Stephans Kevin L.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference7 articles.

1. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer;King;Int J Radiat Oncol Biol Phys,2012

2. Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer;Boike;J Clin Oncol,2011

3. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials;King;Radiother Oncol,2013

4. Stereotactic body radiation therapy for low-, intermediate-, and high-risk prostate cancer: Disease control and quality of life at 6 years;Katz;Int J Radiat Oncol Biol Phys,2013

5. A phase 1/2 trial of brief androgen suppression and stereotactic radiation therapy (FASTR) for high-risk prostate cancer;Bauman;Int J Radiat Oncol Biol Phys,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate–High-Risk Prostate Cancer: Insights from a Phase I/II Study;Cancers;2024-05-31

3. Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).;Strahlentherapie und Onkologie;2024-01-05

4. HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol;BMJ Open;2024-01

5. Five Fractions versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis;Cancers;2023-12-12